Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of Milan

European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
F RaspagliesiM Deraco

Abstract

We report the effects of cytoreductive surgery (CRS) and intraperitoneal hyperthermic perfusion (IPHP) in the treatment of advanced/recurrent epithelial ovarian cancer (EOC) on survival, morbidity and mortality. Forty EOC patients were studied. Median age was 52.5 years (range: 30-68) and median follow-up 26.1 months (range: 0.3-117.6). Most patients presented advanced disease (stage III/IV). Previous systemic chemotherapy included cisplatin-based, taxol-based or taxol/platinum containing regimens. After the CRS, 33 patients presented no macroscopic residual disease. Five-year overall survival was 15%; the mean overall and progression-free survivals were 41.4 and 23.9 months, respectively. The morbidity, toxicity and mortality rates were 5%, 15% and 0%, respectively. Our results suggest that CRS + IPHP merits further evaluation by a formal prospective trial.

References

Jan 11, 1992·Gynecologic Oncology·M E PotterH M Shingleton
Mar 1, 1989·European Journal of Cancer & Clinical Oncology·A de GramontJ Barrat
Sep 1, 1988·Gynecologic Oncology·K C PodratzT O Wilson
Jan 1, 1995·Annals of Surgery·P H Sugarbaker
Aug 8, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·P F ConteC Cianci
Aug 8, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·E D HagerH Strama
Oct 22, 2003·Surgical Oncology Clinics of North America·Paul H Sugarbaker
Jun 30, 2004·World Journal of Surgical Oncology·Pompiliu PisoHans Juergen Schlitt
Aug 7, 2004·Gynecologic Oncology·Ki Sung RyuJoon Mo Lee
Apr 13, 2005·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·J GoriN Felci

❮ Previous
Next ❯

Citations

Nov 3, 2007·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·F C Muñoz-CasaresA Gómez-Portilla
Nov 18, 2009·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Francisco C Muñoz-CasaresJordi Muntané
Dec 7, 2007·Annals of Surgical Oncology·B L van LeeuwenH Mahteme
Dec 12, 2012·Cancer Management and Research·Daniel L ChanTerence C Chua
Nov 14, 2013·World Journal of Gastroenterology : WJG·Federico CoccoliniFausto Catena
Dec 18, 2013·Current Treatment Options in Oncology·Ramez N EskanderRobert E Bristow
Feb 26, 2013·Journal of Gastrointestinal Cancer·Jacopo Giuliani
Jul 26, 2008·Cancer Chemotherapy and Pharmacology·Kurt Van der SpeetenP H Sugarbaker
Oct 2, 2013·Annals of Surgical Oncology·Maryann Kwa, Franco Muggia
Sep 17, 2013·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·P Cascales CamposPascual Parrilla
Apr 12, 2016·Indian Journal of Surgical Oncology·Aditi Bhatt, Olivier Glehen
Aug 27, 2013·Gynécologie, obstétrique & fertilité·E FuretG Houvenaeghel
Dec 24, 2011·Gynécologie, obstétrique & fertilité·N BakrinF Golfier
Jun 17, 2011·European Journal of Obstetrics, Gynecology, and Reproductive Biology·P A CascalesP Parrilla Paricio
Apr 7, 2010·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·D BarattiM Deraco
Feb 2, 2010·Journal de gynécologie, obstétrique et biologie de la reproduction·J-M ClasseL Gladieff
Jun 3, 2008·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·J HanssonH Mahteme
Dec 22, 2006·Cancer Treatment Reviews·R M SmeenkF A N Zoetmulder
Aug 14, 2012·Gastroenterology Research and Practice·Evgenia HalkiaPaul Sugarbaker
Aug 30, 2008·Journal of Surgical Oncology·Shigeki KusamuraMarcello Deraco
Nov 3, 2010·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Terence C ChuaDavid L Morris
Oct 30, 2013·Journal of Surgical Oncology·Kaitlyn J Kelly, Garrett M Nash
Apr 10, 2009·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·M J PavlovD M Kecmanovic
Apr 23, 2015·Critical Reviews in Oncology/hematology·Franco RovielloDaniele Marrelli
Nov 30, 2010·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·M DeracoS Kusamura

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.